Edwards Lifesciences
1,246 hedge funds and large institutions have $41.1B invested in Edwards Lifesciences in 2023 Q1 according to their latest regulatory filings, with 135 funds opening new positions, 450 increasing their positions, 426 reducing their positions, and 99 closing their positions.
36% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 99
25% more call options, than puts
Call options by funds: $174M | Put options by funds: $140M
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
7% more capital invested
Capital invested by funds: $38.4B → $41.1B (+$2.75B)
1% more funds holding
Funds holding: 1,229 → 1,246 (+17)
6% more repeat investments, than reductions
Existing positions increased: 450 | Existing positions reduced: 426
0.56% less ownership
Funds ownership: 82.21% → 81.65% (-0.56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$425M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$237M |
| 3 |
Goldman Sachs
New York
|
+$103M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$63.8M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
+$59.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$241M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$142M |
| 3 |
Amundi
Paris,
France
|
-$127M |
| 4 |
Two Sigma Investments
New York
|
-$116M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$116M |
EW Hedge Fund Activity: Q1 2023 in Review
1,246 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2023, worth a combined $41.1B — up 7.2% from $38.4B a quarter earlier.
Buyers outnumbered sellers: 135 funds opened new EW positions and 99 closed out — a net gain of 36 holders — while 450 added to existing stakes and 426 trimmed.
The largest buyer was DZ Bank, adding an estimated $425M. The largest seller was Millennium Management, cutting an estimated $241M.
- 1,246 institutional investors held Edwards Lifesciences (EW) as of Q1 2023, up from 1,229 in Q4 2022.
- Funds reported $41.1B of Edwards Lifesciences stock for Q1 2023, up 7.2% quarter-over-quarter.
- 135 funds opened new Edwards Lifesciences positions in Q1 2023 and 99 closed out, a net change of +36 holders.
- The largest Edwards Lifesciences buyer in Q1 2023 was DZ Bank, an estimated $425M added.
- The largest Edwards Lifesciences seller in Q1 2023 was Millennium Management, an estimated $241M sold.
Based on aggregated 13F filings for Q1 2023.